Hyperglycemia Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CORT | B | Corcept Therapeutics Incorporated | 2.90 | |
MNKD | C | MannKind Corporation | -0.87 | |
DXCM | D | DexCom, Inc. | -2.19 |
Related Industries: Biotechnology Diagnostics & Research
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
EKG | B | First Trust Nasdaq Lux Digital Health Solutions ETF | 8.48 | |
LGHT | D | Langar Global HealthTech ETF | 5.51 | |
PJP | C | PowerShares Dynamic Pharmaceuticals | 5.29 | |
XPH | B | SPDR S&P Pharmaceuticals ETF | 4.96 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 4.92 |
Compare ETFs
- Hyperglycemia
Hyperglycemia (also spelled hyperglycaemia or hyperglycæmia), also known as high blood sugar, is a condition in which an excessive amount of glucose circulates in the blood plasma. This is generally a blood sugar level higher than 11.1 mmol/l (200 mg/dl), but symptoms may not start to become noticeable until even higher values such as 15–20 mmol/l (~250–300 mg/dl). A subject with a consistent range between ~5.6 and ~7 mmol/l (100–126 mg/dl) (American Diabetes Association guidelines) is considered slightly hyperglycemic, while above 7 mmol/l (126 mg/dl) is generally held to have diabetes. For diabetics, glucose levels that are considered to be too hyperglycemic can vary from person to person, mainly due to the person's renal threshold of glucose and overall glucose tolerance. On average however, chronic levels above 10–12 mmol/L (180–216 mg/dl) can produce noticeable organ damage over time.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles